Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses

  1. Christine M. Posavad*,
  2. David M. Koelle*,,,
  3. Mary F. Shaughnessy*, and
  4. Lawrence Corey*,,,§
  1. Departments of *Laboratory Medicine and Medicine, University of Washington, Seattle, WA 98195, and Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1124 Columbia Street, Room M115, Seattle, WA 98104
  1. Edited by Anthony S. Fauci, National Institute of Allergy and Infectious Diseases, Bethesda, MD, and approved July 16, 1997 (received for review June 9, 1997)

Abstract

The specific mechanisms underlying the varied susceptibility of HIV-infected (HIV+) individuals to opportunistic infections (OI) are still incompletely understood. One hypothesis is that quantitative differences in specific T cell responses to a colonizing organism determine the development of an AIDS-defining OI. We evaluated this hypothesis for herpes simplex virus (HSV) infection, a common OI in HIV+ patients. Using limiting dilution analyses, the frequency of HSV-specific CD8+ cytotoxic T lymphocyte precursors (pCTL) and proliferative precursors were quantitated in peripheral blood mononuclear cells from 20 patients coinfected with HIV and HSV-2. The frequency of HSV-specific CD8+ pCTL in HSV+HIV+ individuals was significantly lower than in HSV+HIV− individuals (1 in 77,000 vs. 1 in 6,000, P = .0005) and was not different than in HSV-HIV− individuals (1 in 100,000, P = .24). HIV+ patients who suffered more severe genital herpes recurrences had significantly lower HSV-specific CD8+ pCTL frequencies than those patients with mild recurrences (1 in 170,000 vs. 1 in 26,000, P = .03). In contrast, no significant difference was seen in proliferative precursor frequencies between those patients with mild vs. severe genital herpes (1 in 3,800 vs. 1 in 6,600, P > .5). Quantitative differences in pCTL frequency to HSV appear to be the most important host factor influencing the frequency and severity of HSV reactivation in HIV+ patients. Studies to reconstitute such immunity, especially in people with acyclovir-resistant HSV, appear warranted.

Footnotes

  • § To whom reprint requests should be addressed. e-mail: lcorey{at}u.washington.edu.

  • This paper was submitted directly (Track II) to the Proceedings Office.

  • Abbreviations: HIV-infected, HIV+; CTL, cytotoxic T lymphocyte; pCTL, cytotoxic T lymphocyte precursor; pProlif, proliferative precursor; HSV-2, herpes simplex virus 2; OI, opportunistic infection; PBMC, peripheral blood mononuclear cells; PHA, phytohemagglutinin; SI, stimulation indices; EBV, Epstein–Barr virus; APC, antigen-presenting cells.

« Previous | Next Article »Table of Contents